about
Molecular Imaging-Guided Interventional Hyperthermia in Treatment of Breast Cancer.The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERαIdentification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer.Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with ERalpha.Targeting autophagy in breast cancer.Radiofrequency heat-enhanced chemotherapy for breast cancer: towards interventional molecular image-guided chemotherapyp66ShcA promotes breast cancer plasticity by inducing an epithelial-to-mesenchymal transition.DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancer.Notch-EGFR/HER2 Bidirectional Crosstalk in Breast CancerLoss of estrogen-regulated microRNA expression increases HER2 signaling and is prognostic of poor outcome in luminal breast cancer.Subtype-specific overexpression of the Rac-GEF P-REX1 in breast cancer is associated with promoter hypomethylation.Rapid detection of genetic mutations in individual breast cancer patients by next-generation DNA sequencingTNFα signaling exposes latent estrogen receptor binding sites to alter the breast cancer cell transcriptomeResistance to everolimus driven by epigenetic regulation of MYC in ER+ breast cancers.The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ.Transformation of enriched mammary cell populations with polyomavirus middle T antigen influences tumor subtype and metastatic potential.Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients.Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis - influence of platelets and fibrin bundles on the behavior of breast tumor cells.Effect of tumor size on breast cancer-specific survival stratified by joint hormone receptor status in a SEER population-based study.Cancer stem cell-driven efficacy of trastuzumab (Herceptin): towards a reclassification of clinically HER2-positive breast carcinomas.Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers.Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patientsNeoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation.Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profilingTargeting BET bromodomain proteins in solid tumorsPancancer modelling predicts the context-specific impact of somatic mutations on transcriptional programs.Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.The Tyrosine Kinome Dictates Breast Cancer Heterogeneity and Therapeutic Responsiveness.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.High expression of FOXR2 in breast cancer correlates with poor prognosis.Association Study Confirmed Three Breast Cancer-Specific Molecular Subtype-Associated Susceptibility Loci in Chinese Han Women.CHST9 rs1436904 genetic variant contributes to prognosis of triple-negative breast cancer.Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.Plasma circulating tumor DNA as an alternative to metastatic biopsies for mutational analysis in breast cancer.Gene network inherent in genomic big data improves the accuracy of prognostic prediction for cancer patients.Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.St Gallen International Expert Consensus on the primary therapy of early breast cancer: an invaluable tool for physicians and scientists.Rat Models of 17beta-Estradiol-Induced Mammary Cancer Reveal Novel Insights into Breast Cancer Etiology and Prevention.
P2860
Q26780500-02386F23-F656-4918-A86F-EA0EBF54C005Q28596581-787C9899-09F5-4615-B482-173124E42B2EQ33704579-448FFC53-E44C-4F10-ACA8-AA0B2189A2ECQ33848844-80B3D0B4-7F1F-41CC-B383-F08CC826F438Q34023616-4240BDF8-DEEE-49D9-B0F7-390C2423EFF2Q34195652-1F8045B6-E576-43FC-8DB6-35EC47536A7DQ34298024-1E89B2B5-291B-435B-82F0-3692BBF15E95Q34484781-33986D0D-FAD7-4DA2-87DD-F23397CD4006Q34686900-BE153667-158F-4399-A926-2FE8D2F99E25Q34979662-178CD651-88E0-4EC9-B80D-EF830D00449CQ35000289-505A44AF-E81B-4F42-9181-411ACFF010F6Q35142605-77C978F6-ACF9-4831-9385-F1A2FA3F77E7Q35269181-C5AFB230-DDE7-48BE-8ADB-0889C1884BA9Q35273689-2389EEC9-583F-4E02-8455-652EDE4E92C1Q35634158-CC797D3A-3092-4983-ACDB-63A98F19BBC2Q36110157-319A1773-5420-4C66-A031-270279EF1812Q36234021-E8705387-603D-44BD-B963-80E100284CAAQ36277239-11F97792-36EF-48F7-91E4-DFE54FD659E1Q36356139-A11B663F-B1FF-483C-A16C-6BFDFD10991DQ36544839-91E11C1B-3772-4E18-9B2E-826D525F9B57Q36547888-23196DA6-9A21-4696-8504-62E790297934Q36597345-C81A5DBE-061A-485F-8ABE-62E8650AF83BQ37376167-3A722375-DACC-44AA-A21F-3314254712EDQ37458486-3D7389CD-AEC6-4D3E-A47B-424F06B3AE73Q37619860-9CBCC7C8-920E-46D7-AFE2-AF9EE39A83FFQ37622585-CC38ED69-5D1F-403C-AA40-03F68EE15195Q38261856-13B95889-AFB7-46DA-AC25-79BB8CE5C40BQ38722836-0DA7B93C-C351-480B-81FF-EAB30D2838CFQ38890318-8AB9C706-D093-4C8E-8F55-7EE04F5AF986Q39214999-7B09AB49-7ED3-4BE8-A709-80751D9DE16CQ41104821-E49E59C7-A05F-45F8-9A0E-01582F2760FFQ41364845-A6517926-7028-4D52-BC0F-0CE945261D8AQ41717913-5E523A85-5ACF-489E-B42A-70CFA8DEFD06Q42078197-46AA1A2F-5321-48AF-ADB4-BCC3D1FC8C33Q44670943-8F74D785-5B84-4797-B70F-EE4A2184D6DEQ45983567-DB828F60-314B-47AE-9478-77398910D7C0Q47162272-C49D4509-63B2-43BC-9CA0-9383DB031EAFQ48112811-F188E9D5-67CC-4F24-B412-D17F950081E1Q49035702-477D2627-4DE9-4E1E-8A3A-67A45F4ECF9FQ49662743-FC4096B6-D896-4938-9E7D-4F75847CEC33
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Luminal breast cancer: from biology to treatment.
@en
type
label
Luminal breast cancer: from biology to treatment.
@en
prefLabel
Luminal breast cancer: from biology to treatment.
@en
P2860
P1476
Luminal breast cancer: from biology to treatment.
@en
P2093
Christos Sotiriou
Michail Ignatiadis
P2860
P304
P356
10.1038/NRCLINONC.2013.124
P407
P577
2013-07-23T00:00:00Z